These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38124622)

  • 1. IgA is the predominant isotype of anti-β2 glycoprotein I in patients with COVID-19.
    Melayah S; Omrani N; Alouini H; Ghozzi M; Mrad S; Boussarsar M; Chaouch H; Hachfi W; Letaief A; Mankaï A; Ghedira I
    Lab Med; 2024 May; 55(3):373-379. PubMed ID: 38124622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgA is the predominant isotype of anti-β2 glycoprotein I antibodies in rheumatoid arthritis.
    Melayah S; Changuel M; Mankaï A; Ghedira I
    J Clin Lab Anal; 2020 Jun; 34(6):e23217. PubMed ID: 31967351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM, but not IgA rheumatoid factor interferes with anti-cardiolipin and antiβ2 glycoprotein I measurements: a quantitative analysis.
    Lakos G; Teodorescu M
    Lupus; 2011 May; 20(6):614-9. PubMed ID: 21436214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
    Chayoua W; Yin DM; Kelchtermans H; Moore GW; Gris JC; Musiał J; Zuily S; Ten Cate H; de Laat B; Devreese KMJ
    Thromb Haemost; 2020 Nov; 120(11):1557-1568. PubMed ID: 32696448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cardiolipin and anti-beta 2-glycoprotein I antibodies in celiac disease.
    Mankaï A; Achour A; Thabet Y; Manoubia W; Sakly W; Ghedira I
    Pathol Biol (Paris); 2012 Oct; 60(5):291-5. PubMed ID: 21839587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
    Devreese KMJ; Linskens EA; Benoit D; Peperstraete H
    J Thromb Haemost; 2020 Sep; 18(9):2191-2201. PubMed ID: 32619328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.
    Pericleous C; Ferreira I; Borghi O; Pregnolato F; McDonnell T; Garza-Garcia A; Driscoll P; Pierangeli S; Isenberg D; Ioannou Y; Giles I; Meroni PL; Rahman A
    PLoS One; 2016; 11(6):e0156407. PubMed ID: 27253369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of antiphospholipid antibodies in primary biliary cirrhosis.
    Mankaï A; Manoubi W; Ghozzi M; Melayah S; Sakly W; Ghedira I
    J Clin Lab Anal; 2015 Jan; 29(1):32-6. PubMed ID: 24687920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Persijn L; Decavele AS; Schouwers S; Devreese K
    Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward harmonized interpretation of anticardiolipin and anti-β2-glycoprotein I antibody detection for diagnosis of antiphospholipid syndrome using defined level intervals and likelihood ratios: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
    Vandevelde A; Gris JC; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ
    J Thromb Haemost; 2024 Aug; 22(8):2345-2362. PubMed ID: 38704123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of IgA antiphospholipid antibodies in diagnosis of the antiphospholipid syndrome].
    Yang B; Zhao JL; Huang ZC; Su ZZ; Li MT; Zeng XF; Hu CJ
    Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(41):3404-3410. PubMed ID: 34758544
    [No Abstract]   [Full Text] [Related]  

  • 13. IgA anti-beta-2 glycoprotein I antibodies in chronic hepatitis C.
    Melayah S; Kallala O; Ben Ahmed M; Fodha I; Yacoub Jemni S; Ghedira I; Mankaï A
    Arab J Gastroenterol; 2022 Feb; 23(1):26-31. PubMed ID: 35123900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome.
    Borghi MO; Beltagy A; Garrafa E; Curreli D; Cecchini G; Bodio C; Grossi C; Blengino S; Tincani A; Franceschini F; Andreoli L; Lazzaroni MG; Piantoni S; Masneri S; Crisafulli F; Brugnoni D; Muiesan ML; Salvetti M; Parati G; Torresani E; Mahler M; Heilbron F; Pregnolato F; Pengo M; Tedesco F; Pozzi N; Meroni PL
    Front Immunol; 2020; 11():584241. PubMed ID: 33178218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
    Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
    J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
    Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
    Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome].
    Fujieda Y; Shida H; Oku K; Bohgaki T; Amengual O; Horita T; Yasuda S; Atsumi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(5):430-6. PubMed ID: 25744643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies in autoimmune thyroid diseases.
    Mankaï A; Melayah S; Bousetta S; Ghozzi M; Yacoub-Jemni S; Ghedira I
    J Clin Lab Anal; 2022 Dec; 36(12):e24788. PubMed ID: 36426963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticardiolipin and anti-beta 2-glycoprotein I antibodies in patients with unexplained articular manifestations.
    Melayah S; Ghozzi M; Ghedira I; Mankaï A
    J Clin Lab Anal; 2023 Jan; 37(1):e24812. PubMed ID: 36514859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.